SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
about
Epstein-Barr virus nuclear antigen 3C interacts with and enhances the stability of the c-Myc oncoproteinEpstein-Barr virus latent antigen 3C can mediate the degradation of the retinoblastoma protein through an SCF cellular ubiquitin ligaseThe Modulation of Apoptotic Pathways by GammaherpesvirusesRole of EBNA-3 Family Proteins in EBV Associated B-cell LymphomagenesisInduction of p16(INK4a) is the major barrier to proliferation when Epstein-Barr virus (EBV) transforms primary B cells into lymphoblastoid cell lines.Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP.Extensive co-operation between the Epstein-Barr virus EBNA3 proteins in the manipulation of host gene expression and epigenetic chromatin modification.Epstein-Barr virus nuclear antigen 3C facilitates G1-S transition by stabilizing and enhancing the function of cyclin D1.Upregulation of the cell-cycle regulator RGC-32 in Epstein-Barr virus-immortalized cells.Epstein-Barr virus nuclear antigen 3C stabilizes Gemin3 to block p53-mediated apoptosis.Epstein-Barr virus nuclear antigen 3A protein regulates CDKN2B transcription via interaction with MIZ-1E2F1 mediated apoptosis induced by the DNA damage response is blocked by EBV nuclear antigen 3C in lymphoblastoid cells.Epstein-Barr virus nuclear antigens 3C and 3A maintain lymphoblastoid cell growth by repressing p16INK4A and p14ARF expression.The EBV Latent Antigen 3C Inhibits Apoptosis through Targeted Regulation of Interferon Regulatory Factors 4 and 8.EBNA3C attenuates the function of p53 through interaction with inhibitor of growth family proteins 4 and 5Epstein-Barr virus nuclear antigen 3C targets p53 and modulates its transcriptional and apoptotic activities.EBNA3C augments Pim-1 mediated phosphorylation and degradation of p21 to promote B-cell proliferationEpstein-Barr virus nuclear protein EBNA3C is required for cell cycle progression and growth maintenance of lymphoblastoid cells.Kaposi's sarcoma herpesvirus-encoded latency-associated nuclear antigen stabilizes intracellular activated Notch by targeting the Sel10 protein.Viral modulators of cullin RING ubiquitin ligases: culling the host defense.EBV-encoded EBNA-6 binds and targets MRS18-2 to the nucleus, resulting in the disruption of pRb-E2F1 complexesThe Role of F-Box Proteins during Viral Infection.Regulation of the retinoblastoma proteins by the human herpesviruses.Epstein-Barr virus nuclear protein EBNA3C residues critical for maintaining lymphoblastoid cell growth.Nucleoside diphosphate kinase/Nm23 and Epstein-Barr virus.Epstein-Barr virus-associated B-cell lymphomas: pathogenesis and clinical outcomes.Viral takeover of the host ubiquitin system.Impact of EBV essential nuclear protein EBNA-3C on B-cell proliferation and apoptosis.Deregulation of the cell cycle machinery by Epstein-Barr virus nuclear antigen 3C.Epstein-Barr virus latency: current and future perspectives.Epstein-Barr virus essential antigen EBNA3C attenuates H2AX expression.Transcriptional downregulation of p27KIP1 through regulation of E2F function during LMP1-mediated transformation.Epstein-Barr virus nuclear antigen 3C augments Mdm2-mediated p53 ubiquitination and degradation by deubiquitinating Mdm2.EBNA3C-mediated regulation of aurora kinase B contributes to Epstein-Barr virus-induced B-cell proliferation through modulation of the activities of the retinoblastoma protein and apoptotic caspasesPhosphorylation of p27Kip1 by Epstein-Barr virus protein kinase induces its degradation through SCFSkp2 ubiquitin ligase actions during viral lytic replication.Therapeutic Strategies against Epstein-Barr Virus-Associated Cancers Using Proteasome Inhibitors.The Cooperative Functions of the EBNA3 Proteins Are Central to EBV Persistence and Latency.Transcriptional and epigenetic modulation of autophagy promotes EBV oncoprotein EBNA3C induced B-cell survival.
P2860
Q24311421-E4D98592-986C-4ADC-92F5-67F07D5BB2B6Q24535609-23166CD0-3F7D-439C-9E7F-AA817FDC28A8Q26747452-32E61B20-B1CB-49C5-BE6A-546FA5741582Q26752541-7D13CC69-5E4C-4A28-AD1E-62DEF67EE57DQ31111648-35AAD315-9D27-4604-9E58-4D6984F88EACQ33604848-308E255D-F808-4C9A-A57A-4CD2E0AA3CACQ33749934-C5542D18-8FEA-455F-A319-3168EB9FE179Q33828576-D653A9A7-62FA-467A-A809-B90248C52E78Q34097970-64DEC160-577B-4A2F-B6C3-4F848C5E0C9EQ34102722-2337529B-5D3B-4C94-B0FE-76D077700905Q34115503-69E24A27-ADDF-444A-BAAC-EE252DF93AF3Q34205875-74E8D760-2C86-4EA4-9D3F-C0F347F8E03AQ34549944-158A4CDF-6B29-4310-9C3D-8485152D2CBEQ34711793-BE7DD040-C855-45B0-9BCD-AD5514B62285Q34741776-7C89BD6C-405C-4426-890D-4DF739D4CA84Q34872837-BE56BB07-A27C-463A-9DB7-6A8F1A4211A6Q35224422-E77F8C7E-3B4E-4D48-AF18-0AE3C1E7AED6Q35540042-8D0A270B-A3E6-406B-8918-6FCEDB34FA45Q36019173-E7003261-B184-47C6-8EA2-F5DA5D1C933DQ36480678-BBDB65E0-4CE8-44F2-B34B-FB2E8ED16F26Q36535405-D76243A5-3AA9-46BD-A70F-8D9D6BEC744CQ36656176-25D9BCCC-CD4D-46A3-9D8A-D7B6D3373A65Q37085853-20244951-C505-4CEA-A111-2239178030F3Q37132783-B0A3410B-926A-47AC-A126-54738978B52EQ37468665-5489D5BC-2CA6-4AAF-A13B-B586BA17ED9FQ37849461-60B85569-C5B2-4563-8312-2E62B2F13D0EQ37918803-8E52FCA9-9AA7-4305-92F6-C9DADD84E6BEQ38086861-9A962CCD-D839-430A-AB3F-1375B0208243Q38337443-233E106C-7E46-4BE2-8BE6-78F424F804BCQ38603533-2C51FFCA-820A-464A-A65C-C467A1489B24Q38854742-A7DFFBBD-5256-4427-962D-7DB6740B3D84Q39787510-D0980B89-FC09-4A49-9E5B-438CC6ED9C85Q39879529-BA17E45D-2021-46E2-878A-3BF0F86C020AQ42273501-C4CDA230-A20C-43D6-BAF1-095E395CEC04Q43099184-99A757D9-CFC7-4340-A8AC-CA8CAE451012Q45324502-AC3F4836-4142-4B27-BBF1-729487631DC1Q54251658-17C8B6CD-DFEF-4BD1-BF54-00B4B9B5A20EQ54978478-909C2F58-ABED-4F88-A998-DA1AFADF7EAF
P2860
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
description
2005 nî lūn-bûn
@nan
2005 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի մարտին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年学术文章
@wuu
2005年学术文章
@zh-cn
2005年学术文章
@zh-hans
2005年学术文章
@zh-my
2005年学术文章
@zh-sg
2005年學術文章
@yue
name
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@ast
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@en
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@nl
type
label
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@ast
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@en
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@nl
prefLabel
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@ast
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@en
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@nl
P2860
P3181
P1476
SCFSkp2 complex targeted by Epstein-Barr virus essential nuclear antigen
@en
P2093
Jason S Knight
Nikhil Sharma
P2860
P304
P3181
P356
10.1128/MCB.25.5.1749-1763.2005
P407
P577
2005-03-01T00:00:00Z